Literature DB >> 28571141

Evaluation of Masood's and Modified Masood's Scoring Systems in the Cytological Diagnosis of Palpable Breast Lump Aspirates.

Smrithi Krishna Cherath1, Savithri Moothiringode Chithrabhanu2.   

Abstract

INTRODUCTION: Fine Needle Aspiration Cytology (FNAC) has a leading role in the assessment of breast lesions. Masood's Scoring Index (MSI) and its modification (Modified Masood's scoring index; MMSI) has been proposed to aid in sub-grouping breast lesions and to help in subsequent management. AIM: To assess and compare the diagnostic accuracy of MSI and MMSI by subsequent correlation with histopathology.
MATERIALS AND METHODS: The study was cross-sectional in nature and was conducted in a tertiary care setting. The study included 207 cases presenting as palpable breast lump, which had undergone FNAC and subsequent excision biopsy for histopathology. STATISTICAL ANALYSIS: The cases were grouped into four categories as suggested by Masood et al., (MSI) and Nandini et al., (MMSI) and concordance analysis with reference to histopathological diagnosis was done.
RESULTS: In comparison to MSI, MMSI showed better concordance with histopathological diagnosis and superior diagnostic accuracy in non-proliferative breast disease category (p-value = 0.046) as well as in proliferative breast disease without atypia category. The overall diagnostic accuracy of the cytological scoring was 97.5%, with 94.5% sensitivity and 100% specificity.
CONCLUSION: Though both MSI and MMSI were found effective in subcategorizing breast lesions, MMSI was found to have better concordance with histopathology. Inclusion of cellular pattern and background material may further help in increasing the accuracy.

Entities:  

Keywords:  Breast carcinoma; Fine needle aspiration cytology of breast; Non-proliferative breast disease; Proliferative breast disease

Year:  2017        PMID: 28571141      PMCID: PMC5449787          DOI: 10.7860/JCDR/2017/22817.9558

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

1.  Cytologic features of proliferative breast disease: a study designed to minimize sampling error.

Authors:  A R Frost; S O Tabbara; L A Poprocky; H Weiss; M K Sidawy
Journal:  Cancer       Date:  2000-02-25       Impact factor: 6.860

Review 2.  Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.

Authors:  Shahla Masood
Journal:  Clin Lab Med       Date:  2005-12       Impact factor: 1.935

3.  Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature.

Authors:  N M Nandini; T S Rekha; G V Manjunath
Journal:  Indian J Cancer       Date:  2011 Apr-Jun       Impact factor: 1.224

4.  Needle cytology of the breast. A quantitative and qualitative study of the cells of benign and malignant ductal neoplasia.

Authors:  B R Dziura; T A Bonfiglio
Journal:  Acta Cytol       Date:  1979 Jul-Aug       Impact factor: 2.319

5.  Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions.

Authors:  J S Thomas; E A Mallon; W D George
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

6.  Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.

Authors:  Asit Ranjan Mridha; Venkateswaran K Iyer; Kusum Kapila; Kusum Verma
Journal:  Indian J Pathol Microbiol       Date:  2006-07       Impact factor: 0.740

Review 7.  Cancer risk and diet in India.

Authors:  R Sinha; D E Anderson; S S McDonald; P Greenwald
Journal:  J Postgrad Med       Date:  2003 Jul-Sep       Impact factor: 1.476

8.  Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.

Authors:  N Sneige; G A Staerkel
Journal:  Hum Pathol       Date:  1994-05       Impact factor: 3.466

9.  Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates.

Authors:  S Masood; E R Frykberg; G L McLellan; S Dee; J B Bullard
Journal:  Diagn Cytopathol       Date:  1991       Impact factor: 1.582

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.